| Dear Colleague,
Following the excellent response to our call for abstracts, we are pleased to inform you that we have extended the abstract submission deadline for CRISPR: From Biology to Technology and Novel Therapeutics until June 23, 2017, to allow participants additional time to complete their submissions.
Here is a reminder of our exciting speaker line-up:
- Charlie Albright, Chief Scientific Officer, Editas Medicine,USA
- Chase Beisel, North Carolina State University, USA
- Juan-Carlos Izpisua Belmonte, Salk Institute, USA
- Paula Cannon, University of Southern California, USA
- Jacob Corn, University College Berkeley, USA
- Alan Davidson, University of Toronto, Canada
- Charles Gersbach, Duke University, USA
- Maria Jasin, Sloan-Kettering Cancer Center, USA
- Martin Jinek, University of Zurich, Switzerland
- J. Keith Joung, Massachusetts General Hospital, Harvard Medical School, USA
- Nancy Maizels, University of Washington, USA
- Andy May, Chan-Zuckerberg BioHub, USA
- Luigi Naldini, Telethon Institute Milan, Italy
- Tony Nolan, Imperial College London, UK
- John van der Oost, Waginengen University, The Netherlands
- Michel Sadelain, Sloan Kettering Cancer Center, USA
- Blake Wiedenheft, Montana State University, USA
Don’t miss your chance to present your own CRISPR research at this unique symposium.
Yours sincerely,
J. Keith Joung, Massachusetts General Hospital, Harvard Medical School, USA
Andrew May, Chan-Zuckerberg BioHub, USA
John Pham, Chief Editor, Molecular Cell
Jonathan Saxe, Editor, Cell Stem Cell |
